Current major cancer targets for nanoparticle systems

Current Cancer Drug Targets

Volumn 11, Issue 2, 2011, Pages 164-183

  Wesselinova, D ^a  

^a Department of Experimental Morphology   (Bulgaria)

Author keywords

Biological toxicity; Cancer imaging; Cancer treatment; Nano particles

Indexed keywords

AMINOLEVULINIC ACID; ANTINEOPLASTIC AGENT; CARBON NANOTUBE; CHITOSAN; CHROMIUM; CISPLATIN; COBALT; COSMETIC; GOLD NANOPARTICLE; INFLUENZA VACCINE; LIPOSOME; METAL; NANOCAPSULE; NANOCRYSTAL; NANOMATERIAL; NANOPARTICLE; NANOROD; NANOWIRE; OXIDE; PALLADIUM COMPLEX; PLATINUM COMPLEX; QUANTUM DOT; SILICON DIOXIDE; SILVER; SILVER NANOPARTICLE; SINGLE WALLED NANOTUBE; SUNSCREEN; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TITANIUM DIOXIDE; UNINDEXED DRUG;

AIR POLLUTION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER DIAGNOSIS; CARDIOVASCULAR DISEASE; CELL DEATH; CELL FUNCTION; CELL ORGANELLE; CERAMICS; CHEMICAL COMPOSITION; CLAY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DNA DAMAGE; DRUG DELIVERY SYSTEM; GASTROINTESTINAL TOXICITY; HUMAN; INFLAMMATION; LUBRICATION; LUNG TOXICITY; MESENCHYMAL STEM CELL; MORTALITY; NANOTECHNOLOGY; NEAR INFRARED REFLECTANCE SPECTROSCOPY; NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PARTICLE SIZE; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; SEMICONDUCTOR; SKIN TOXICITY;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; HUMANS; NANOMEDICINE; NANOPARTICLES; NEOPLASMS;

EID: 79551652066     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800911794328484     Document Type: Article

References (159)

1. Buzea, C.; Blandino, I. I. P.; Robbie, K. Nanomaterials and nanoparticles: Sources and toxicity. Biointerphases 2007, 2, MR17-MR172
2. Daigle, C. C.; Chalupa, D. C.; Gibb, F. R.; Morrow, P. E.; Oberdörster, G.; Utell, M. J.; Frampton, M. W. Ultrafine particle deposition in humans during rest and exercise. Inhal. Toxicol.2003, 15, 539-552.
3. Oberdörster, G.; Maynard, A.; Donaldson, K.; Castranova, V.; Fitzpatrick, J.; Ausman, K.; Carter, J.; Karn, B.; Kreyling, W.; Lai, D.; Olin, S.; Monteiro-Riviere, N.; Warheit, D.; Yang, H.; ILSI Research Foundation/Risk Science Institute Nanomaterial Toxicity Screening Working Group. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part. Fibre Toxicol. 2005a, 2, 8.
4. Wilson, R.; Spengler, J. Emissions, dispersion and concentration of particles. In: Particles in Our Air: Concentrations and Health Effects (Wilson R, Spengler J, eds). Cambridge, MA:Harvard University Press, 1996, pp. 41-84.
5. Oberdörster, G.; Oberdörster, E.; Oberdörster, J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005b, 113, 823-839.
6. Grassian, V. H.; OShaughnessy, P. T.; Adamcakova-Dodd, A.; Pettibone, J. M.; Thorne, P. S. Inhalation exposure study of titanium dioxide nanoparticles with a primary particle size of 2 to 5 nm. Environ. Health Perspect. 2007, 115, 397-402.
7. Sapkota, A.; Symons, J. M.; Kleissl, J.; Wang, L.; Parlange, M. B.; Ondov, J.; Breysse, P. N.; Diette, G. B.; Eggleston, P.A.; Buckley, T. J. Impact of the 2002 canadian forest fires on particulate matter air quality in baltimore city. Environ. Sci. Technol. 2005, 39, 24-32
8. Ning, Z.; Cheung, C. S.; Fu, J.; Liu, M. A.; Schnell, M. A. Experimental study of environmental tobacco smoke particles under actual indoor environment. Sci. Total Environ. 2006, 367, 822-830.
9. Nemery, B. Metal toxicity and the respiratory tract. Eur. Respir. J. 1990, 3, 202-219.
10. Myllynen, P. Nanotoxicology: damaging DNA from a distance. Nat. Nanotechnol. 2009, 4(No 12); pp. 795-796.
11. Bhabra, G.; Sood, A.; Fisher, B.; Cartwright, L.; Saunders, M.; Evans, W. H.; Surprenant, A.; Castejon, G. L.; Mann, S.; Davis, S. A.; Hails, L. A.; Ingham, E.; Verkade, P.; Lane, J.; Heesom, K.; Newson, R.; Case, C. P. Nanoparticles can cause DNA damage across a cellular barrier. Nat. Nanotechnol. 2009, 4(12), 876-883.
12. Risom, L.; Moller, P.; Loft, S. Oxidative stress-induced DNA damage by particulate air pollution. Mutat. Res. 2005, 592, 119-137.
13. Peters, A.; Veronesi, B.; Calderon-Garciduenas, L.; Gehr, P.; Chen, L. C.; Geiser, M.; Reed, W.; Rothen-Rutishauer, B.; Schurch, S.; Schultz, H. Translocation and potential neurological effects of fine and ultrafine particles. A critical update. Part. Fibre Toxicol. 2006, 3, 13.
14. Donaldson, K.; Stone, V. Current hypotheses on the mechanisms of toxicity of ultrafine particles. Ann. Ist. Super Sanita 2003, 39, 405-410.
15. Brown, D. M.; Donaldson, K.; Borm, P. J.; Schins, R. P.; Dehnhardt, M.; Gilmour, P.; Jimenez, L. A.; Stone, V. Calcium and ROS-mediated activation of transcription factors and TNF-α cytokine gene expression in macrophages exposed to ultrafine particles Iam. J. Physiol. Lung Cell. Mol. Physiol. 2004, 286, L344-L353.
16. Long, H.; Shi, T.; Borm, P. J.; Määttä, J.; Husgafvel-Pursiainen, K.; Savolainen, K.; Krombach, F. ROSmediated TNF-α and MIP-2 gene expression in alveolar macrophages exposed to pine dust. Part. Fibre Toxicol. 2004, 1, 3
17. Pisanic, T. R.; Blackwell, J. D.; Shubayev, V.I.; Fiñones, R. R.; Jin, S. Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials 2007, 28 (16), 2572-2581.
18. Wang, H-J.; Yang, L.; Yang, H-Y.; Wang, K.; Yao, W-G.; Jiang, K.; Huang, X-L.; Zheng, Z. Antineoplastic activities of proteinconjugated silver sulfide nano-crystals with different shapes. J. Inorg. Biochem. 2010, 104(1), 87-91.
19. Kim, K-J.; Sung, W.S.; Suh, B.K.; Moon, S-K.; Choi, J.-S.; Kim, J.K.; Lee, D.G. Antifungal activity and mode of action of silver nano-particles on Candida albicans. Biometals 2009, 22, 235-242.
20. Yamada, T.; Ueda, M.; Seno, M.; Kondo, A.; Tanizawa, K.; Kuroda, S. Novel tissue and cell type-specific gene/drug delivery system using surface engineered hepatitis B virus nano-particles. Curr. Drug Targets Infect. Disord. 2004, 4(2), 163-7.
21. Hamelers, I. H. L.; Staffhorst, R.W. H. M.; Voortman, J.; de Kruijffl, B.; Reedijk, J.; van Bergenen Henegouwen, P. M. P.; de Kroon, A. I. P. M. High cytotoxicity of cisplatin nanocapsules in ovarian carcinoma cells depends on uptake by caveolae-mediated endocytosis. Clin. Cancer Res., 2009, 15, 1259.
22. 2 long-term exposure. Toxicol. Appl. Pharmacol. 2009, 241, 182-194.
23. Wesselinova, D.; Neykov, M.; Kaloyanov, N.; Toshkova, R.; Dimitrov, G. Antitumor activity of novel 1,10- phenanthroline and 5- amino-1,10- phenanthroline derivatives. Eur. J. Med. Chem. 2009a, 44, 2720-2723.
24. Wesselinova, D.; Kaloyanov, N.; Dimitrov, G. Cytotoxicity and effects of 1,10-phenanthroline and 5-amino- 1,10- phenanthroline derivatives on some immunocompetent cells. Eur. J. Med. Chem. 2009b, 44, 5099-5102.
25. Gurr, J. R.; Wang, A. S. S.; Chen, C. H.; Jan, K. Y. Ultrafine titanium dioxide particles in the absence of photoactivation can induce oxidative damage to human bronchial epithelial cells. Toxicol. 2005, 213, 66-73.
26. 2 in a tracheal explant system. Am. J. Physiol. 1998, 274, L81-L86
27. Takenaka, S.; Karg, E.; Roth, C.; Schulz, H.; Ziesenis, A.; Heinzmann, U.; Schramel, P.; Heyder, J. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ. Health Perspect. 2001, 109 (Suppl. 4), 547-551.
28. Zheng, Y.; Sanche, L. Gold nanoparticles enhance DNA damage induced by anti-cancer drugs and radiation. Radiat. Res. 2009, 172(1), 114-119.
29. Petrarca, C.; Perrone, A.; Verna, N.; Verginelli, F.; Ponti, J.; Sabbioni, E.; Di Giampaolo, L.; Dadorante, V.; Schiavone, C.; Boscolo, P.; Costantini, R. M.; Di Gioacchino, M. Cobalt nanoparticles modulate cytokine in vitro release by human mononuclear cells mimicking autoimmune disease. Int. J. Immunopathol. Pharmacol. 2006, 19(4 Suppl), 11-4.
30. Liu, J.; Wong, H. L.; Moselhy, J.; Bowen, B.; Wu, X. Y.; Johnston, M. R. Targeting colloidal particulates to thoracic lymph nodes. Lung Cancer 2006, 51 377-386
31. Shwe, T. T. W.; Yamamoto, S.; Kakeyama, M.; Kobayashi, T.; Fujimaki, H. Effect of intratracheally instillation of untrafine carbon black on proinflammatory cytokine and chemokine release and mRNA expression in lung and lymph nodes of mice. Toxicol. Appl. Pharmacol. 2005, 209, 51-61.
32. Nemmar, A.; Hoylaerts, M. F.; Hoet, P. H.; Dinsdale, D.; Smith, T.; Xu, H.; Vermylen, J.; Nemery, B. Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am. J. Respir. Crit. Care Med. 2002a, 166, 998-1004.
33. Vermylen, J.; Nemmar, A.; Nemery, B.; Hoylaerts, F. Ambient air pollution and acute myocardial infarction J. Thromb. Haemost. 2005, 3, 1955-1961.
34. Hoet, P. H. M.; Brüske-Hohlfeld, I.; Salata, O. V. Nanoparticles - known and unknown health risks. J. Nanobiotechnol. 2004, 2, doi:10.1186/1477-3155-2-12.
35. Cooper, J. R.; Stradling, G. N.; Smith, H.; Breadmore, S. E. The reactions of 1.0 nanometre diameter plutonium-238 dioxide particles with rat lung fluid. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 1979, 36, 453-466.
36. Nohynek, G. J.; Lademann, J.; Ribaud, C.; Roberts, M. S. Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety. Crit. Rev. Toxicol. 2007, 37, 251-277.
37. Oberdörster, G.; Ferin, J.; Gelein, R.; Soderholm, S. C.; Finkelstein, J. Role of the alveolar macrophage in lung injury: studies with ultrafine particles. Environ. Health Perspect. 1992, 97, 193-199.
38. Poon, V. K.; Burd, A. In vitro cytotoxicity of silver: implication for clinical wound care. Burns 2004, 30, 140-147.
39. Antonini, J. M.; Santamaria, A. B.; Jenkins, N. T.; Albini, E.; Lucchini, R. Fate of manganese associated with the inhalation of welding fumes: potential neurological effects. NeuroToxicology 2006, 27, 304-310.
40. Bourrinet, P.; Bengele, H. H.; Bennemain, B.; Dencausse, A.; Idee, J. M.; Jacobs, P. M.; Lewis, J. M. Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent. Investig. Radiol. 2006, 41, 313-324.
41. Rabin, O.; Perez, J. M.; Grimm, J.; Wojtkiewiccz, G.; Weissleder, R. An X-ray computed tomography imaging agent on longcirculating bismuth sulphide nanoparticles. Nat. Mater. 2006, 5, 118-122.
42. Thibodeau, G. A; Patton, K. T. Anatomy and Physiology, 5th ed. Mosby Inc., St. Luis 2003.
43. Lucarelli, M.; Gatti, A. M.; Savarino, G.; Quattroni, P.; Martinelli, L. E.; Boraschi, D. Innate defence functions of macrophages can be biased by nano-sized ceramic and metallic particles. Eur. Cytokine Netw. 2004, 15, 339-346.
44. Kim, J.; Takahashi, M.; Shimizu, T.; Shirasawa, T.; Kajita, M.; Kanayama, A.; Miyamoto, Y. Effects of a potent antioxidant, platinum nanoparticle, on the lifespan of Caenorhabditis elegans. Mech. Ageing Dev. 2008, 129 (6), 322-331.
45. Borm, P. J.; Kreyling, W. Toxicological hazards of inhaled nanoparticles - potential implications for drug delivery. J. Nanosci. Nanotechnol. 2004, 4(5), 521-531.
46. Medina, C.; Santos-Martinez, M. J.; Radomski, A.; Corrigan, O. I.; Radomski, M. W. Nanoparticles: pharmacological and toxicological significance. Br. J. Pharmacol. 2007, 150(5), 552-558.
47. Zhao, G.; Sun, H.; Lin, H.; Zhu, S.; Su, X.; Chen, Y. Palladium(II) complexes with N,N'-dialkyl-1,10-phenanthroline-2,9-dimathanamine: synthesis, characterization and cytotoxic activity. J. Inorg. Biochem. 1998, 72(3-4),173-7.
48. Okamoto, S.; Matsuura, M.; Akagi, T.; Akashi, M.; Tanimoto, T.; Ishikawa, T.; Takahashi, M.; Yamanishi, K.; Mori, Y. Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice. Vaccine 2009, 27, 5896-905.
49. Song, Y.; Li, X.; Du, X. Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma. Eur. Respir. J. 2009, 34, 559-567.
50. M. Effects of fiber characteristics on lung deposition, retention, and disease. Environ. Health Perspect. 1990, 88, 311-317.
51. Moore, M. A.; Brown, R.C.; Pigott, G. Material properties of MMVFs and their time-dependent failure in lung environments. Inhal. Toxicol. 2001, 13, 1117-1149.
52. G. Pulmonary effects of inhaled ultrafine particles. Int. Arch. Occup. Environ. Health 2001, 74, 1-8.
53. Oberdorster, G. Toxicokinetics and effects of fibrous and nonfibrous particles. Inhal. Toxicol. 2002b, 14, 29-56.
54. Warheit, D. B.; Hart, G. A.; Hesterberg, T. W.; Collins, J. J.; Dyer, W. M.; Swaen, G. M.; Castranova, V.; Soiefer, A. I.; Kennedy, G. L. Potential pulmonary effects of man-made organic fiber (MMOF) dusts. Crit. Rev. Toxicol. 2001, 31, 697-736.
55. Service, R. F. Nanomaterials show signs of toxicity. Science 2003, 300, 243.
56. Warheit, D. B.; Laurence, B. R.; Reed, K. L.; Roach, D. H.; Reynolds, G.A.; Webb, T. R. Comparative pulmonary toxicity assessment of single wall carbon nanotubes in rats. Toxicol. Sci. 2003, 77, 117-125.
57. Lam, C. W.; James, J. T.; McCluskey, R.; Hunter, R. L. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol. Sci. 2003, 77, 126-134.
58. Lee, K. P.; Kelly, D. P.; Schneider, P. W.; Trochimowicz, H. J. Inhalation toxicity study on rats exposed to titanium tetrachloride atmospheric hydrolysis products for two years. Toxicol. Appl. Pharmacol. 1986, 83, 30-45.
59. Hoet, P. H.; Gilissen, L. P.; Leyva, M.; Nemery, B. In vitro cytotoxicity of textile paint components linked to the Ardystil syndrome. Toxicol. Sci. 1999, 52, 209-216.
60. Fischer, D.; Li, Y.; Ahlemeyer, B.; Krieglstein, J.; Kissel, T. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 2003, 24, 1121-1131.
61. Nemmar, A.; Nemery, B.; Hoylaerts, M. F.; Vaermylen, J. Air pollution and thrombosis: an experimental approach. Pathophysiol. Haemost. Thromb. 2002b, 32, 349-350.
62. Peters, A.; Liu, E.; Verrier, R. L.; Schwartz, J.; Gold, D. R.; Mittleman, M.; Baliff, J.; Oh, J. A.; Allen, G.; Monahan, K.; Dockery, D. W. Air pollution and incidence of cardiac arrhythmia. Epidemiology 2000, 11, 11-17.
63. Akerman, M. E.; Chan, W. C.; Laakkonen, P.; Bhatia, S. N.; Ruoslahti, E. Nanocrystal targeting in vivo. Proc. Natl. Acad. Sci. USA 2002, 99, 12617-12621.
64. Ryser, H. J. A membrane effect of basic polymers dependent on molecular size. Nature 1967, 215, 934-936.
65. Geiser, M.; Schurch, S.; Gehr, P. Influence of surface chemistry and topography of particles on their immersion into the lung's surface- lining layer. J. Appl. Physiol. 2003, 94, 1793-1801.
66. Yeates, D. B.; Mauderly, J. L. Inhaled environmental/occupational irritants and allergens: mechanisms of cardiovascular and systemic responses: Introduction. Environ. Health Perspect. 2001, 109, 479-481.
67. Aprahamian, M.; Michel, C.; Humbert, W.; Devissaguet, J. P.; Damge, C. Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine. Biol. Cell 1987, 61, 69-76.
68. Hussain, N.; Florence, A. T. Utilizing bacterial mechanisms of epithelial cell entry: invasin- induced oral uptake of latex nanoparticles. Pharm. Res. 1998, 15, 153-156.
69. L. Light microscopical observations on luminally administered dyes, dextrans, nanospheres and microspheres in the preepithelial mucus gel layer of the rat distal colon. J. Control Release 1997, 46, 233-242.
70. Lomer, M. C.; Thompson, R. P.; Powell, J. J. Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn's disease. Proc. Nutr. Soc. 2002, 61, 123-130.
71. Lademann, J.; Weigmann, H.; Rickmeyer, C.; Barthelmes, H; Schaefer, H.; Mueller, G.; Sterry, W. Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol. Appl. Skin Physiol. 1999, 12, 247-256.
72. M. Influence of microemulsions on cutaneous drug delivery. Adv. Drug Deliv. Rev. 2002, 54, S77-S98.
73. Tinkle, S. S.; Antonini, J. M.; Rich, B. A.; Roberts, J. R.; Salmen, R.; DePree, K.; Adkins, E. J. Skin as a route of exposure and sensitization in chronic beryllium disease. Environ. Health Perspect. 2003, 111, 1202-1208.
74. Andersson, K. G.; Fogh, C. L.; Byrne, M. A.; Roed, J.; Goddard, A. J.; Hotchkiss, S. A. Radiation dose implications of airborne contaminant deposition to humans. Health Phys. 2002, 82, 226-232.
75. Lademann, J.; Otberg, N.; Richter, H.; Weigmann, H. J.; Lindemann, U.; Schaefer, H.; Sterry, W. Investigation of follicular penetration of topically applied substances. Skin Pharmacol. Appl. Skin Physiol. 2001, 14, 17-22.
76. De Jalon, E. G.; Blanco-Prieto, M. J.; Ygartua, P.; Santoyo, S. PLGA microparticles: possible vehicles for topical drug delivery. Int. J. Pharm. 2001, 226, 181-184.
77. Labhasetwar, V.; Song, C.; Humphrey, W.; Shebuski, R.; Levy, R. J. Arterial uptake of biodegradable nanoparticles: effect of surface modifications. J. Pharm. Sci. 1998, 87, 1229-1234.
78. Davda, J.; Labhasetwar, V. Characterization of nanoparticle uptake by endothelial cells. Int. J. Pharm. 2002, 233, 51-59.
79. Boland, S.; Baeza-Squiban, A.; Fournier, T.; Houcine, O.; Gendron, M. C.; Chevrier, M.; Jouvenot, G.; Coste, A.; Aubier, M.; Marano, F. Diesel exhaust particles are taken up by human airway epithelial cells in vitro and alter cytokine production. Am. J. Physiol. 1999, 276, L604-L613.
80. Juvin, P.; Fournier, T.; Boland, S.; Soler, P.; Marano, F.; Desmonts, J. M.; Aubier, M. Diesel particles are taken up by alveolar type II tumor cells and alter cytokines secretion. Arch. Environ. Health 2002, 57, 53-60.
81. McMinn, L.H.; Hodges, G. M.; Carr, K. E. Gastrointestinal uptake and translocation of microparticles in the streptozotocin-diabetic rat. J. Anat. 1996, 189, 553-559.
82. Hoet, P. H.; Nemery, B. Stimulation of phagocytosis by ultrafine particles. Toxicol. Appl. Pharmacol. 2001, 176, 203.
83. Brown, J.S.; Zeman, K. L.; Bennett, W. D. Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am. J. Respir. Crit. Care Med. 2002, 166, 1240-1247.
84. Lundborg, M.; Johard, U.; Lastbom, L.; Gerde, P.; Camner, P. Human alveolar macrophage phagocytic function is impaired by aggregates of ultrafine carbon particles. Environ. Res. 2001, 86, 244-253.
85. Mossman, B. T.; Sesko, A. M. In vitro assays to predict the pathogenicity of mineral fibers. Toxicology 1990, 60, 53-61.
86. Oberdorster, G. Lung particle overload: implications for occupational exposures to particles. Regul. Toxicol. Pharmacol. 1995, 21, 123-135.
87. Fernandez-Urrusuno, R.; Fattal, E.; Feger, J.; Couvreur, P.; Therond, P. Evaluation of hepatic antioxidant systems after intravenous administration of polymeric nanoparticles. Biomaterials 1997, 18, 511-517.
88. Eyles, J. E.; Bramwell, V. W.; Williamsson, E. D.; Alpar, H. O. Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration. Vaccine 2001, 19, 4732-4742.
89. M. Endemic non-filarial elephantiasis of lower-limbs - podoconiosis. Med. Clin. 1988, 91, 97-100.
90. Powell, J. J.; Ainley, C. C.; Harvey, R. S.; Mason, I. M.; Kendall, M. D.; Sankey, E. A.; Dhillon, A. P.; Thompson, R. P. Characterisation of inorganic microparticles in pigment cells of human gut associated lymphoid tissue. Gut 1996, 38, 390-395.
91. Kucharzik, T.; Lugering, A.; Lugering, N.; Rautenberg, K.; Linnepe, M.; Cichon, C.; Reichelt, R.; Stoll, R.; Schmidt, M. A.; Domschke, W. Characterization of M cell development during indomethacin- induced ileitis in rats. Aliment. Pharmacol. Ther. 2000, 14, 247-256.
92. Pratten, M. K.; Lloyd, J. B. Uptake of microparticles by rat visceral yolk sac. Placenta 1997, 18, 547-552.
93. Alyaudtin, R. N.; Reichel, A.; Lobenberg, R.; Ramge, P.; Kreuter, J.; Begley, D. J. Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro. J. Drug Target 2001, 9, 209-221.
94. Ning, N.; Peng, Z. F.; Yuan, L.; Gou, B. D.; Zhang, T. L.; Wang, K. Realgar nano-particles induce apoptosis and necrosis in leukemia cell lines K562 and HL-60. Zhongguo Zhong Yao Za Zhi 2005 30(2), 136-40.
95. Li, Y.; Leung, P.; Yao, L.; Song, Q. W.; Newton, E. Antimicrobial effect of surgical masks coated with nanoparticles. J. Hosp. Infect. 2006, 62, 58-63.
96. Bosi, S.; da Ros, T.; Spalluto, G.; Prato, M. Fullerene derivatives: an attractive tool for biological applications. Eur. J. Med. Chem. 2003, 38, 913-923.
97. Brayner, R.; Ferrari-Iliou, R.; Brivois, N.; Djediat, S.; Benedetti, M. F.; Fievet, F. Toxicological impact studies based on Esterichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium. Nano Lett. 2006, 6, 866-870.
98. Reijnders, L. Cleaner nanotechnology and hazard reduction of manufactured nanoparticles. J. Cleaner Production 2006, 14, 124-133.
99. Dimitrov, G.; Kaloyanov, N.; Petrov, P.; Wesselinova, D. Antibacterial activity of novel compounds obtained on interaction of 1,10- phenanthroline with alkaline earth metal ions, palladium (II) and NaBF4. Comptes rendus de l'Academie bulgare des Sciences 2008, 61, 595-602.
100. Bender, A.R.; von Briesen, H.; Kreuter, J.; Duncan, I. B.; Rübsamen-Waigmann, H. Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro. Antimicrob. Agents Chemother. 1996, 40, 1467-71.
101. Hafner, J. H.; Cheung, C. L.; Woolley, A. T.; Lieber, C. M. Structural and functional imaging with carbon nanotube AFM probes. Prog. Biophys. Mol. Biol. 2001, 77, 73-110.
102. Uhrich, K. E.; Cannizzaro, S. M.; Langer, R. S.; Shakeshelf, K. M. Polymeric systems for controlled drug release. Chem. Rev. 1999, 99, 3181-3198.
103. Harisinghani, M. G.; Barentsz, J.; Hahn, P. F.; Deserno, W. M.; Tabatabaei, S.; van de Kaa, C. H.; de la Rosette, J.; Weissleder, R. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N. Engl. J. Med. 2003, 19, 2491-2499.
104. Sapra, P.; Tyagi, P.; Allen, T. M. Ligand-targeted liposomes for cancer treatment. Curr. Drug Deliv. 2005, 2, 369-381.
105. Ferrari, M. Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer 2005, 5, 161-171.
106. Moghimi, S. M.; Hunter, A. C.; Murray, J. C. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev. 2001, 53, 283-318.
107. LaVan, D, A.; McGuire, T.; Langer, R. Small-scale systems for in vivo drug delivery. Nat. Biotechnol. 2003, 21, 1184-1191.
108. Fassas, A.; Anagnostopoulos, A. The use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemia. Leuk. Lymphoma 2005, 46, 795-802.
109. Jain, T. K.; Morales, M. A.; Sahoo, S. K.; Leslie-Pelecky, D.L.; Labhasetwar, V. Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol. Pharm. 2005, 2, 194-205.
110. Deryugina, E. I.; Quigley, J. P. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006, 25, 9-34.
111. Cuenca, A. G.; Jiang, H.; Hochwald, S. N.; Delano, M.; Cance, W. G.; Grobmyer, S. R. Emerging implications of nanotechnology on cancer diagnostics and therapeutics. Cancer 2006, 107, 459-466.
112. Northfelt, D. W.; Martin, F. J.; Working, P.; Volberding, P. A.; Russell, J.; Newman, M.; Amantea, M. A.; Kaplan, L. D. Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma. J. Clin. Pharmacol. 1996, 36, 55-63.
113. Stohrer, M.; Boucher, Y.; Stangassinger, M.; Jain, R. K. Oncotic pressure in solid tumors is elevated. Cancer Res. 2000, 60, 4251-4255.
114. Atri, M. New technologies and directed agents for applications of cancer imaging. J. Clin. Oncol. 2006, 24, 3299-3308.
115. Weissleder, R. Molecular imaging in cancer. Science 2006, 312, 1168-1171.
116. A. Molecular imaging of cancer using PET and SPECT. Adv. Exp. Med. Biol. 2006, 587, 277-284.
117. Chan, W.C.; Nie, S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 1998, 281, 2016-2018.
118. Abey, D. E.; Nishino, N.; McDonnel, W. F.; Burchette, R. J.; Knutsen, S. F.; Beeson, W. L.; Yang, J. X. Long term inhalable particles and other air pollutants related to mortality in non-smokers. Am. J. Respir. Crit. Care Med. 1999, 159, 373-382.
119. Pope, C. A.; Burnett, R. T.; Thun, M. J.; Calle, E. E.; Krewski, D.; Ito, K.; Thurston, G. D. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 2002, 286, 1132-1141.
120. Iwai, K.; Mizuno, S.; Miyasaka, Y.; Mori, T. Correlation between suspended particles in the environmental air and causes of disease among inhabitants: cross-sectional studies using the vital statistics and air pollution data in Japan. Environ. Res. 2005, 99, 106-117.
121. Knox, E. G. Oil combustion and childhood cancers J. Epidemiol. Community Health 2005, 59, 755-760.
122. Xie, C.; Xu, F.; Huang, X.; Dong, C.; Ren, J. Single gold nanoparticles counter: ultrasensitive dtection platform for one-step homogenous immunoassays and DNA hybridization assays. J. Am. Chem. Soc., 2009, 131, 12763-12770.
123. Rembacken, B.; Fujii, T.; Kondo, H. The recognition and endoscopic treatment of early gastric and colonic cancer. Best Pract. Res. Clin.Gastroenterol. 2001, 15, 317-336.
124. Allison, R. R.; Mota, H. C.; Sibata, C. H. Clinical PD/PDT in North America: an historical review. Photodiagn. Photodyn. Ther. 2004, 1, 263-277.
125. Allison, R. R.; Cuenca, R.; Downie, G. H.; Randall, M. E.; Bagnato, V. S.; Sibata, C. H. PD/PDT for gynecological disease: a clinical review. Photodiagn. Photodyn. Ther., 2005, 2, 51-63.
126. Yang, S-J.; Shieh, M-J.; Lin, F-H.; Lou, P-J.; Peng, C-L.; Wei, MF.; Yao, C-J.; Lai, P-S.; Young, T-H. Colorectal cancer cell detection by 5-aminolaevulinic acid-loadedchitosan nano-particles. Cancer Lett. 2009, 273, 210-220.
127. Kennedy, J. C.; Pottier, R. H.; Ross, D. C. Photodynamic therapy with endogenous protoporphyrin: basic principles and present clinical experience. J. Photochem. Photobiol. B 1990, 6, 143-148.
128. Stelutia, R.; Rosa, F. S. D.; Collett, J.; Tedesco, A. C.; Bentley, M. V. L. B. Topical glycerol monooleate/propylene glycol formulations enhance 5-aminolevulinic acid in vitro skin delivery and in vivo protophorphyrin IX accumulation in hairless mouse skin. Eur. J. Pharm. Biopharm. 2005, 60, 439-444.
129. Du, J.; Zhang, S.; Sun, R.; Zhang, L. F.; Xiong, C. D.; Peng, Y. X. Novel polyelectrolyte carboxymethyl konjac glucomannan-chitosan nanoparticles for drug delivery. II Release of albumin in vitro. J. Biomed. Mater. Res. Part B 2005, 72B, 299-304.
130. Loebinger, M. R.; Kyrtatos, P. G.; Turmaine, M.; Price, A. N.; Pankhurst, Q.; Lythgoe, M. F.; Janes, S.M. Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. Cancer Res. 2009, 69(23), 8862-7.
131. Vigor, K. L.; Kyrtatos, P. G.; Minogue, S., Al-Jamal, K. T.; Kogelberg, H.; Tolner, B.; Kostarelos, K.; Begent, R. H.; Pankhurst, Q. A.; Lythgoe, M. F.; Chester, K. A. Nanoparticles functionalized with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells. Biomaterials 2010, 31(6), 1307-15.
132. Caires, A. C. F. Recent advances involving palladium (II) complexes for the cancer therapy. Anti-Cancer Agents Med. Chem. 2007, 7(5), 484-491.
133. Huq, F.; Daghriri, H.; Yu, J. Q.; Beale, P.; Fisher, K. Studies on the synthesis and characterization of four trans-planaramineplatinum (II) complexes of the form trans-PtL(NH3)CL2 where L = 2- hydroxypyridine, 3-hydroxypyridine, imidazole, and imidazo(1,2- alpha)pyridine. Eur. J. Med. Chem. 2004, 39 (8), 691-697.
134. Chowdhury, A.; Huq, F.; Abdullach, A.; Beale, P.; Fisher, K. Synthesis, characterization and binding with DNA of four planaramineplatinum(II) complexes of the forms: trans-PtL2Cl2 and [PtL3Cl]Cl, where L = 3-hydroxypyridine, 4-hydroxypyridine and imidazo(1,2-alpha)pyridine. J. Inorg. Chem., 2005, 99, 1098-112.
135. Berners-Price, S.; Appleton, T.G. The chemistry of cisplatin in aqueous solution, in: Kelland, L.R.; Farrell, N.P. Eds. Platinum- Based Drugs in Cancer Therapy. Humana Press, Totowa, NJ, USA, 2000, pp. 3-35.
136. Malinowska, K.; Modranka, R.; Kubiak, K.; Mrowicka, M.; Klimczak, A.; Kedziora, J.; Rutkowski, M. Testing antineoplastic activity of new platinum(II) and palladium(II) complex compounds. Pol. Merkur. Lekarski. 2009, 26(151), 57-61.
137. Lin, H. X.; Li, Z. L.; Dai, G. L.; Bi, Q. S.; Yu, R. Q. Preliminary fluorimetric screening of fourteen palladium complexes as potential antitumor agents. Sci. China B. 1993, 36(10), 1216-23.
138. Keter, F. K.; Kanyanda, S.; Sylvester, S.; Lyantagaye, L.; Darkwa, J. D.; Jasper, G.; Rees, J. G.; Meyer, M. In vitro evaluation of dichloro bis(pyrazole)palladium(II) and dichloro-bis(pyrazole) platinum(II) complexes as anticancer agents. Cancer Chemother. Pharmacol. 2008, 63, 127-138.
139. Huq, F.; Tayyem, H.; Beale, P.; Yu, J. Q. Studies on the activity of three palladium(II) compounds of the form: Trans-PdL2Cl2 where L = 2-hydroxypyridine, 3-hydroxypyridine, and 4-hydroxypyridine. J. Inorg. Biochem. 2007, 101, 30-35.
140. Valentini, A.; Conforti, F.; Crispini, A.; Martino, A.de.; Condello, R.; Stellitano, C.; Rotilio, G.; Ghedini, M.; Federici, G.; Bernardini, S.; Pucci, D. Synthesis, oxidant properties, and antitumoral effects of a heteroleptic palladium(II) complex of curcumin on human prostate cancer cells. J. Med. Chem. 2009, 52(2), 484-491.
141. Radulovic, S.; Tesic, Z.; Manic, S. Trans-platinum complexes as anticancer drugs: recent developments and future prospects. Curr. Med. Chem. 2002, 17, 1611-18.
142. Brudzinska, I.; Mikata, Y.; Obata, M.; Ohtsukic, C.; Yanoa, S. Synthesis, structural characterization, and antitumor activity of palladium(II) complexes containing a sugar unit. Bioorg. Med. Chem. Lett. 2004, 14, 2533-2536.
143. Pelka, J.; Gehrke, H.; Esselen, M.; Turk, M.; Crone, M.; Brse, S.; Muller, T.; Blank, H.; Send, W.; Zibat, V.; Brenner, P.; Schneider, R.; Gerthsen, D.; Marko, D. Cellular uptake of platinum nanoparticles in human colon carcinoma cells and their impact on cellular redox systems and DNA integrity. Chem. Res. Toxicol. 2009, 22(4), 649-659.
144. Staffhorst, R.W.; van der Born, K.; Erkelens, C. A.; Hamelers, I. H.; Peters, G. J.; Boven, E.; de Kroon, A. I. Antitumor activity and biodistribution of cisplatin nanocapsules in nude mice bearing human ovarian carcinoma xenografts. Anticancer Drugs 2008, 19(7), 721-7.
145. Ray, S.; Mohan, R.; Singh, J. K.; Samantaray, N. K.; Shaikh, M. M.; Dulal Panda, D.; Ghosh, P. Anticancer and antimicrobial metallopharmaceutical agents based on palladium, gold, and silver nheterocyclic carbene complexes. J. Am. Chem. Soc. 2007, 129(48), 15042-15053.
146. Wang, X.; Yang, L.; Chen, Z. G.; Shin, D. M. Application of nanotechnology in cancer therapy and imaging. CA Cancer J. Clin. 2008, 58, 97-110.
147. Allen, T. M.; Sapra, P.; Moase, E.; Moreira, J.; Iden, D. Adventures in targeting. J. Liposome Res. 2002, 12(1-2), 5-12.
148. Fan, X.; Zhang, D.; Zheng, J.; Gu, N.; Ding, A.; Jia, X.; Qing, H.; Jin, L.; Wan, M.; Li, Q. Preparation and characterization of magnetic nano-particles with radiofrequency-induced hyperthermia for cancer treatment. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2006, 4, 809-13.
149. Hainfeld, J. F.; Slatkin, D. N.; Smilowitz, H. M. The use of gold nanoparticles to enhance radiotherapy in mice. Phys. Med. Biol. 2004, 49, 309-315.
150. Kukowska-Latallo, J-F.; Candido, K.A.; Cao, Z.; Nigawekar, S. S.; Majoros, I. J.; Thomas, T. P.; Balogh, L. P.; Khan, M. K.; Baker, J. P. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res. 2005, 65, 5325-36.
151. Benny, O.; Fainaru, O.; Adini, A.; Cassiola, F.; Bazinet, L.; Adini, I.; Pravda, E.; Nahmias, Y.; Koirala, S.; Corfas, G.; D'Amato, R. J. & Folkman, J. An orally delivered small-molecule formulation with antiangiogenic and anticancer activity. Nat. Biotechnol. 2008, 26, 799-807.
152. Makidon, P. E.; Nigavekar, S. S.; Bielinska, A. U.; Mank, N.; Shetty, A. M.; Suman, J.; Knowlton, J.; Myc, A; Rook, T.; Baker, J. R. Characterization of stability and nasal delivery systems for immunization with nanoemulsion-based vaccines. J. Aerosol. Med. Pulm. Drug Deliv. 2010, 23(2), 77-89.
153. Stathopoulos, G. P.; Boulikas, T.; Vougiouka, M.; Deliconstantinos, G.; Rigatos, S.; Darli, E.; Viliotou, V.; Stathopoulos, J.G. Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): phase I study. Oncol Rep. 2005, 13(4), 589-595.
154. Hamelers, I. H. L.; de Kroon, A. I. P. M. Nanocapsules: A novel lipid formulation platform for platinum-based anti-cancer drugs. J. Liposome Res. 2007, 17, No. 3-4, 183-189.
155. Bucking, M.; Dickson, E. F. G.; Farahani, M.; Fischer, F.; Holmes, D.; Jori, G.; Kennedy, J. C.; Kenney, M. E.; Peng, X.; Pottier, R. H.; Weagle, G. Quantification of the selective retention of palladium octabutoxynaphthalocyanine, a potential photothermal drug, in mouse tissues. J. Photochem. Photobiol. B 2000, 58, 87-93.
156. Weiss, M. B.; Aplin, A. E. Paying particle attention to novel melanoma treatment strategies. J. Invest. Dermatol. 2010, 130, 2699-2701.
157. Subbiah, R.; Veerapandian, M.; Yun, K. S. Nanoparticles: functionalization and multifunctional applications in biomedical sciences. Curr Med Chem. 2010 Nov 10. [Epub ahead of print]
158. Roa, W. H.; Azarmi, S.; Al-Hallak, M. H.; Finlay, W. H.; Magliocco, A. M.; Löbenberg, R. Inhalable nanoparticles, a noninvasive approach to treat lung cancer in a mouse model. J. Control Release 2010 Nov 5. [Epub ahead of print]
159. Sriram, M. I.; Kanth, S. B.; Kalishwaralal, K.; Gurunathan, S. Antitumor activity of silver nanoparticles in Dalton's lymphoma ascites tumor model. Int. J. Nanomed. 2010, 5, 753-62.